Karl Haslam
Impact in
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Papers in
- Genetics 23
- Myeloproliferative Neoplasms: Diagnosis and Treatment 19
- Chronic Lymphocytic Leukemia Research 4
- Hematology 22
- Chronic Myeloid Leukemia Treatments 14
- Acute Myeloid Leukemia Research 12
- Co-authors
- Stephen E. Langabeer (26 shared papers)Eibhlin Conneally (13 shared papers)Bertha Brodin (2 shared papers)Yuntao Xie (2 shared papers)Olle Larsson (2 shared papers)Armando Bartolazzi (2 shared papers)Maria Starborg (1 shared paper)Alessandra Gasbarri (1 shared paper)
- Journals
- British Journal of Haematology (2 papers)Blood (2 papers)Pediatric Blood & Cancer (2 papers)Clinical & Translational Oncology (1 paper)Gene (1 paper)
- Partner nations
- IrelandUnited KingdomUnited States
In The Last Decade
Karl Haslam
26 papers receiving 263 citations
Peers
Comparison fields: 5 of 39
- Genetics 142
- Hematology 130
- Rheumatology 87
- Pulmonary and Respiratory Medicine 80
- Pathology and Forensic Medicine 33
Countries citing papers authored by Karl Haslam
This map shows the geographic impact of Karl Haslam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Haslam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Haslam more than expected).
Fields of papers citing papers by Karl Haslam
This network shows the impact of papers produced by Karl Haslam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Haslam. The network helps show where Karl Haslam may publish in the future.
Co-authors
The 25 scholars most cited alongside Karl Haslam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation. | 2002 | 52 |
| 2 | 2001 | 47 | |
| 3 | 2015 | 44 | |
| 4 | 2014 | 19 | |
| 5 | 2017 | 17 | |
| 6 | 2012 | 16 | |
| 7 | 2015 | 9 | |
| 8 | 2016 | 8 | |
| 9 | 2011 | 7 | |
| 10 | 2018 | 6 | |
| 11 | 2016 | 6 | |
| 12 | 2014 | 5 | |
| 13 | 2016 | 4 | |
| 14 | 2010 | 4 | |
| 15 | 2016 | 4 | |
| 16 | 2017 | 3 | |
| 17 | 2014 | 3 | |
| 18 | 2017 | 2 | |
| 19 | 2016 | 2 | |
| 20 | 2014 | 2 |
About Karl Haslam
Karl Haslam is a scholar working on Genetics, Hematology, Molecular Biology, Rheumatology and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 267 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers), Chronic Myeloid Leukemia Treatments (14 papers), Acute Myeloid Leukemia Research (12 papers), Eosinophilic Disorders and Syndromes (12 papers), Kruppel-like factors research (11 papers), Chronic Lymphocytic Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Genetics (142 citations), Hematology (130 citations), Rheumatology (87 citations), Pulmonary and Respiratory Medicine (80 citations) and Pathology and Forensic Medicine (33 citations). Karl Haslam has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include Stephen E. Langabeer, Eibhlin Conneally, Bertha Brodin, Yuntao Xie, Olle Larsson, Armando Bartolazzi, Maria Starborg, Alessandra Gasbarri, Ke Yang and Björn Skytting. Their work appears in journals such as British Journal of Haematology, Blood, Pediatric Blood & Cancer, Clinical & Translational Oncology and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.